Dr. Huseyin Erhan Dincer, MD

Dr. Dincer practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Dincer's NPI, 1255344537, was assigned on August 15, 2006. Dr. Dincer holds Minnesota license 53553.

Dr. Dincer's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Dincer's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Dincer is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Dincer to 1 more hospital, 4 group practices and clinics, 4 medical groups, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dincer practices, 9 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dincer's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dincer is licensed in Minnesota.

CMS data shows 29 Medicare services from Dr. Dincer across 2 procedure codes in 2024, for 82 Medicare patients. Medicare paid $3,330 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Dincer in 2024. The largest group is 65 to 74, with 39 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dincer's median patient age at 69, with 66% women.

In 2024, Dr. Dincer wrote 100 Medicare Part D claims for 20 patients. 29% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $17,300 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Dincer for performance year 2024, reported as part of a group. Dr. Dincer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dincer as offering telehealth.

Dmand AI links 39 papers to Dr. Dincer, published from 2014 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Bronchoscopy, Tomography, X-Ray Computed and Biopsy. Dr. Dincer has published most often in J Bronchology Interv Pulmonol. Dr. Dincer's most frequent co-authors are Felix Daniel Zamora, MD, Rafael Santiago Andrade, MD and Roy Joseph Cho, MD.

CMS Open Payments shows 33 general payments to Dr. Dincer from 14 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 74% of the total. Boston Scientific Corporation paid the most, $4,176.